# OPGEN INC: Form D filings

OPGEN INC, a biotechnology company in Rockville, MD, filed 21 Form D notices with the SEC between 2009 and 2022. The latest, on October 12, 2022, reports $3.4 million sold of a $3.4 million offering to 1 investor.

Find out what OPGEN INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20OPGEN%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=OPGEN%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fopgen-inc-1293818)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20OPGEN%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=OPGEN%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fopgen-inc-1293818)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Maryland](https://specstream.ai/data/form-d/state/maryland): 608 rows, by operating companies, filed since November 1, 2024, $30.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/maryland
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 9717 KEY WEST AVENUE, SUITE 100, Rockville, MD, 20850
- Phone: (301) 869-9683
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1293818

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 12, 2022 | New notice | $3,381,338 | $3,381,338 | $0 | 1 | Oct 3, 2022 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000107997322001317/0001079973-22-001317-index.htm) |
| Feb 24, 2021 | New notice | $25,000,000 | $25,000,000 | $0 | 1 | Feb 11, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381821000001/0001293818-21-000001-index.htm) |
| Dec 4, 2020 | New notice | $10,000,000 | $9,974,027 | $25,973 | 1 | Nov 25, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381820000002/0001293818-20-000002-index.htm) |
| Aug 3, 2018 | New notice | $285,512 | $285,512 | $0 | 1 | Jul 30, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381818000001/0001293818-18-000001-index.htm) |
| Sep 21, 2017 | New notice | $110,000 | $110,000 | $0 | 1 | Sep 13, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381817000002/0001293818-17-000002-index.htm) |
| Jun 20, 2017 | New notice | $1,500,000 | $500,000 | $1,000,000 | 2 | Jun 6, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381817000001/0001293818-17-000001-index.htm) |
| May 27, 2016 | New notice | $10,355,005 | $7,227,504 | $3,127,501 | 10 | May 19, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381816000005/0001293818-16-000005-index.htm) |
| Jul 23, 2015 | New notice | $2,584,090 | $2,584,090 | $0 | 4 | Jul 14, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381815000003/0001293818-15-000003-index.htm) |
| Feb 23, 2015 | New notice | $1,500,000 | $1,243,999 | $256,001 | 9 | Feb 17, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381815000002/0001293818-15-000002-index.htm) |
| Jul 17, 2014 | New notice | $1,500,000 | $1,079,917 | $420,083 | 4 | Jul 11, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381814000003/0001293818-14-000003-index.htm) |
| Apr 4, 2014 | Amendment | $4,000,000 | $3,999,864 | $136 | 29 | Dec 18, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381814000001/0001293818-14-000001-index.htm) |
| Dec 30, 2013 | New notice | $2,000,000 | $1,999,867 | $133 | 29 | Dec 18, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381813000001/0001293818-13-000001-index.htm) |
| Mar 14, 2012 | New notice | $17,000,000 | $6,100,000 | $10,900,000 | 28 | Mar 5, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381812000003/0001293818-12-000003-index.htm) |
| Feb 16, 2012 | Amendment | $3,699,209 | $3,532,442 | $166,767 | 27 | Nov 8, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381812000001/0001293818-12-000001-index.htm) |
| Dec 9, 2011 | New notice | $2,299,209 | $2,132,442 | $166,767 | 27 | Nov 8, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381811000002/0001293818-11-000002-index.htm) |
| Feb 22, 2011 | Amendment | $15,722,858 | $11,935,601 | $3,787,257 | 33 | Sep 21, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381811000001/0001293818-11-000001-index.htm) |
| Oct 6, 2010 | New notice | $15,722,858 | $9,211,141 | $6,511,717 | 15 | Sep 21, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381810000004/0001293818-10-000004-index.htm) |
| May 10, 2010 | Amendment | $8,186,000 | $4,018,522 | $4,167,478 | 13 | Mar 23, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381810000003/0001293818-10-000003-index.htm) |
| Mar 31, 2010 | New notice | $8,186,000 | $4,000,000 | $4,186,000 | 11 | Mar 23, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381810000002/0001293818-10-000002-index.htm) |
| Jan 15, 2010 | Amendment | $4,052,000 | $4,018,336 | $33,664 | 14 | Nov 30, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381810000001/0001293818-10-000001-index.htm) |
| Dec 11, 2009 | New notice | $4,052,000 | $2,000,000 | $2,052,000 | 12 | Nov 30, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1293818/000129381809000004/0001293818-09-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Johannes Donald Bacher | Executive Officer |  |
| William E. Rhodes III | Director |  |
| Prabhavathi Donald Fernandes | Director |  |
| R. Donald Elsey | Director |  |
| Mario E. Crovetto | Director |  |
| Albert Donald Weber | Executive Officer |  |
| Oliver Donald Schacht | Executive Officer, Director |  |

## Other biotechnology companies in Maryland that filed recently

- [BlueHealer Inc.](https://specstream.ai/data/form-d/company/bluehealer-inc-2162934) $1 · Nov 4, 2026
- [Accufy Diagnostics, Inc.](https://specstream.ai/data/form-d/company/accufy-diagnostics-inc-2089723) $2 million · Oct 28, 2026
- [OS Therapies Inc](https://specstream.ai/data/form-d/company/os-therapies-inc-1795091) $7.2 million · Oct 23, 2026
- [Kaigene, Inc.](https://specstream.ai/data/form-d/company/kaigene-inc-1919055) $55 million · Oct 14, 2026
- [Templar Nova, Inc.](https://specstream.ai/data/form-d/company/templar-nova-inc-2158642) $7 million · Oct 7, 2026
- [Monocacy Therapeutics Inc.](https://specstream.ai/data/form-d/company/monocacy-therapeutics-inc-2137361) $25,000 · Oct 7, 2026
- [Seraxis Holdings, Inc.](https://specstream.ai/data/form-d/company/seraxis-holdings-inc-1845486) $10 million · Sep 24, 2026
- [Uvantis Therapeutics, Inc.](https://specstream.ai/data/form-d/company/uvantis-therapeutics-inc-2156954) $100,000 · Sep 23, 2026
- [Gliknik Inc](https://specstream.ai/data/form-d/company/gliknik-inc-1411569) $15 million · Sep 17, 2026
- [Georgiamune, Inc.](https://specstream.ai/data/form-d/company/georgiamune-inc-2148230) $92.7 million · Aug 17, 2026

[Every Form D from the week of Oct 10, 2022](https://specstream.ai/data/form-d/week/2022-10-10) · [All recent filings in Maryland](https://specstream.ai/data/form-d/state/maryland) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what OPGEN INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).